November 27, 2024
LLY, NVO, HIMS: GLP-1 Coverage Questions & Implied Sales
Following our pre-rule report yesterday on CMS’s proposal to extend Medicare / Medicaid coverage to anti-obesity medications (AOMs), we update our assumptions below based on the details included in the release itself. More specifically: We…